The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 No. 349

PART 3 U.K. General matters relating to pharmaceutical lists and applications in respect of them

Current needs: consequences of additional matters U.K.

14.—(1) If [F1 NHS England] is satisfied as mentioned in regulation 13(2)(a), it may—

(a) defer determination of the application;

(b) invite applications from other persons to offer to meet the current need mentioned in regulation 13(1) that the applicant is offering to meet; and

(c) consider, at the same time as the applicant's application, any application it receives—

(i) as a consequence of the invitation issued in accordance with sub-paragraph (b), or

(ii) that, even if it was not received in response to that invitation, is in any event from another person offering to meet the current need mentioned in regulation 13(1) that the applicant is offering to meet,

but it must not defer consideration of the application for longer than 6 months.

(2) If [F1 NHS England] is satisfied as mentioned in regulation 13(2)(b), it may defer consideration of the application until it can be considered at the same time as the other application.

(3) If [F1 NHS England] is satisfied as mentioned in regulation 13(2)(c), it may defer consideration of the application until after the appeal has reached its final outcome.

(4) If [F1 NHS England] is satisfied as mentioned in regulation 13(2)(d) or (e), it must refuse the application.

(5) If [F1 NHS England] is satisfied as mentioned in regulation 13(2)(f) to (h), it may only grant the application if it is satisfied that to do so would secure improvements, or better access, to pharmaceutical services in the area of the relevant HWB.

Textual Amendments

F1 Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1